J9144 Daratumumab, hyaluronidase
Also known as: daratumumab SC, Darzalex SC
Intravenous injection of daratumumab with hyaluronidase-fihj, a monoclonal antibody targeting CD38 with subcutaneous hyaluronidase for subcutaneous delivery.
In Plain Language
multiple myeloma-targeting antibody; subcutaneous cancer therapy
Clinical Context
Subcutaneous formulation of daratumumab for multiple myeloma treatment, allowing faster subcutaneous administration.
RVU Information
CPT J9144 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9144?
CPT J9144 (Daratumumab, hyaluronidase) is a J Codes (Drugs) code. Intravenous injection of daratumumab with hyaluronidase-fihj, a monoclonal antibody targeting CD38 with subcutaneous hyaluronidase for subcutaneous delivery.
How is J9144 administered?
CPT J9144 is administered by a healthcare provider, typically via injection or infusion. Subcutaneous formulation of daratumumab for multiple myeloma treatment, allowing faster subcutaneous administration. It is used by Hematology/Oncology, Medical Oncology.
When is CPT J9144 used?
Subcutaneous formulation of daratumumab for multiple myeloma treatment, allowing faster subcutaneous administration.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.